EquityEquity - ConsumptionVery High Risk
Direct
NAV (01-Jul-25)
Returns (Since Inception)
Fund Size
₹274 Cr
Expense Ratio
0.93%
ISIN
INF966L01DN7
Minimum SIP
₹1,000
Exit Load
1.00%
Inception Date
25 Jan 2024
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
-6.30%
— (Cat Avg.)
Since Inception
+3.42%
— (Cat Avg.)
Equity | ₹258.97 Cr | 94.51% |
Others | ₹15.04 Cr | 5.49% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Nca-Net Current Assets | Cash | ₹-31.76 Cr | 11.59% |
Treps 02-Jun-2025 Depo 10 | Cash - Repurchase Agreement | ₹29.86 Cr | 10.90% |
Reliance Industries Ltd | Equity | ₹28.03 Cr | 10.23% |
Marico Ltd | Equity | ₹24.74 Cr | 9.03% |
ITC Ltd | Equity | ₹23.89 Cr | 8.72% |
Ventive Hospitality Ltd | Equity | ₹23.73 Cr | 8.66% |
Future on Colgate-Palmolive (India) Ltd | Equity - Future | ₹23.35 Cr | 8.52% |
Zydus Wellness Ltd | Equity | ₹22.17 Cr | 8.09% |
Medplus Health Services Ltd | Equity | ₹20.11 Cr | 7.34% |
Stanley Lifestyles Ltd | Equity | ₹15.78 Cr | 5.76% |
Aditya Birla Lifestyle Brands Limited | Equity | ₹15.12 Cr | 5.52% |
Suraksha Diagnostic Ltd | Equity | ₹13.79 Cr | 5.03% |
United Breweries Ltd | Equity | ₹12.82 Cr | 4.68% |
91 Days Tbill Red 12-06-2025 | Bond - Gov't/Treasury | ₹7.99 Cr | 2.91% |
Bajaj Auto Ltd | Equity | ₹7.94 Cr | 2.90% |
Procter & Gamble Hygiene and Health Care Ltd | Equity | ₹7.78 Cr | 2.84% |
Future on Bajaj Auto Ltd | Equity - Future | ₹7.34 Cr | 2.68% |
Aurobindo Pharma Ltd | Equity | ₹6.69 Cr | 2.44% |
91 Days Tbill Red 19-06-2025 | Bond - Gov't/Treasury | ₹2.99 Cr | 1.09% |
Bata India Ltd | Equity | ₹2.2 Cr | 0.80% |
Colgate-Palmolive (India) Ltd | Equity | ₹2.16 Cr | 0.79% |
91 Days Tbill Red 05-06-2025 | Bond - Gov't/Treasury | ₹2 Cr | 0.73% |
India (Republic of) | Bond - Short-term Government Bills | ₹1.99 Cr | 0.72% |
91 Days Tbill Red 21-08-2025 | Bond - Gov't/Treasury | ₹1.98 Cr | 0.72% |
Aditya Birla Fashion and Retail Ltd | Equity | ₹0.8 Cr | 0.29% |
Future on Aurobindo Pharma Ltd | Equity - Future | ₹0.51 Cr | 0.19% |
Large Cap Stocks
24.53%
Mid Cap Stocks
28.78%
Small Cap Stocks
35.69%
AAA
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Consumer Defensive | ₹93.57 Cr | 34.15% |
Consumer Cyclical | ₹50.45 Cr | 18.41% |
Healthcare | ₹40.59 Cr | 14.81% |
Energy | ₹28.03 Cr | 10.23% |
Standard Deviation
This fund
--
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Since January 2024
Since January 2024
Since January 2024
Since February 2025
Since March 2025
Since February 2025
Since March 2025
ISIN INF966L01DN7 | Expense Ratio 0.93% | Exit Load 1.00% | Fund Size ₹274 Cr | Age 1 year 5 months | Lumpsum Minimum ₹5,000 | Fund Status Open Ended Investment Company | Benchmark BSE Consumer Discretionary TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Your principal amount will be at Very High Risk
EquityEquity - ConsumptionVery High Risk
Direct
NAV (01-Jul-25)
Returns (Since Inception)
Fund Size
₹274 Cr
Expense Ratio
0.93%
ISIN
INF966L01DN7
Minimum SIP
₹1,000
Exit Load
1.00%
Inception Date
25 Jan 2024
Your principal amount will be at Very High Risk
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
-6.30%
— (Cat Avg.)
Since Inception
+3.42%
— (Cat Avg.)
Equity | ₹258.97 Cr | 94.51% |
Others | ₹15.04 Cr | 5.49% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Nca-Net Current Assets | Cash | ₹-31.76 Cr | 11.59% |
Treps 02-Jun-2025 Depo 10 | Cash - Repurchase Agreement | ₹29.86 Cr | 10.90% |
Reliance Industries Ltd | Equity | ₹28.03 Cr | 10.23% |
Marico Ltd | Equity | ₹24.74 Cr | 9.03% |
ITC Ltd | Equity | ₹23.89 Cr | 8.72% |
Ventive Hospitality Ltd | Equity | ₹23.73 Cr | 8.66% |
Future on Colgate-Palmolive (India) Ltd | Equity - Future | ₹23.35 Cr | 8.52% |
Zydus Wellness Ltd | Equity | ₹22.17 Cr | 8.09% |
Medplus Health Services Ltd | Equity | ₹20.11 Cr | 7.34% |
Stanley Lifestyles Ltd | Equity | ₹15.78 Cr | 5.76% |
Aditya Birla Lifestyle Brands Limited | Equity | ₹15.12 Cr | 5.52% |
Suraksha Diagnostic Ltd | Equity | ₹13.79 Cr | 5.03% |
United Breweries Ltd | Equity | ₹12.82 Cr | 4.68% |
91 Days Tbill Red 12-06-2025 | Bond - Gov't/Treasury | ₹7.99 Cr | 2.91% |
Bajaj Auto Ltd | Equity | ₹7.94 Cr | 2.90% |
Procter & Gamble Hygiene and Health Care Ltd | Equity | ₹7.78 Cr | 2.84% |
Future on Bajaj Auto Ltd | Equity - Future | ₹7.34 Cr | 2.68% |
Aurobindo Pharma Ltd | Equity | ₹6.69 Cr | 2.44% |
91 Days Tbill Red 19-06-2025 | Bond - Gov't/Treasury | ₹2.99 Cr | 1.09% |
Bata India Ltd | Equity | ₹2.2 Cr | 0.80% |
Colgate-Palmolive (India) Ltd | Equity | ₹2.16 Cr | 0.79% |
91 Days Tbill Red 05-06-2025 | Bond - Gov't/Treasury | ₹2 Cr | 0.73% |
India (Republic of) | Bond - Short-term Government Bills | ₹1.99 Cr | 0.72% |
91 Days Tbill Red 21-08-2025 | Bond - Gov't/Treasury | ₹1.98 Cr | 0.72% |
Aditya Birla Fashion and Retail Ltd | Equity | ₹0.8 Cr | 0.29% |
Future on Aurobindo Pharma Ltd | Equity - Future | ₹0.51 Cr | 0.19% |
Large Cap Stocks
24.53%
Mid Cap Stocks
28.78%
Small Cap Stocks
35.69%
AAA
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Consumer Defensive | ₹93.57 Cr | 34.15% |
Consumer Cyclical | ₹50.45 Cr | 18.41% |
Healthcare | ₹40.59 Cr | 14.81% |
Energy | ₹28.03 Cr | 10.23% |
Standard Deviation
This fund
--
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Since January 2024
Since January 2024
Since January 2024
Since February 2025
Since March 2025
Since February 2025
Since March 2025
ISIN INF966L01DN7 | Expense Ratio 0.93% | Exit Load 1.00% | Fund Size ₹274 Cr | Age 1 year 5 months | Lumpsum Minimum ₹5,000 | Fund Status Open Ended Investment Company | Benchmark BSE Consumer Discretionary TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Get your portfolio reviewed by experts
Download Wealth Monitor App
Track and monitor all
your investments